<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001655'>Patent foramen ovale</z:hpo> (<z:mp ids='MP_0004225'>PFO</z:mp>) represents the most common persistent abnormality of fetal origin </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of the study was to analyze the incidence and characteristics of <z:mp ids='MP_0004225'>PFO</z:mp> and to assess <z:mp ids='MP_0004225'>PFO</z:mp> as the risk factor of <z:e sem="disease" ids="C0238096" disease_type="Disease or Syndrome" abbrv="">paradoxical embolism</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>945 consecutive pts (442F and 503M aged 13-85, mean 53.02 +/- 14.42 years) in whom TEE was performed and flow through <z:mp ids='MP_0004225'>PFO</z:mp> was detected in basal conditions (colour-Doppler) and/or during provocation (Valsalva/cough manoeuvre) with contrast (saline infusion) at the period 1998-2002 was retrospectively analyzed </plain></SENT>
<SENT sid="3" pm="."><plain>183 pt had a history of systemic embolisation (SE) or <z:hpo ids='HP_0002326'>transient ischemic attack</z:hpo> (<z:hpo ids='HP_0002326'>TIA</z:hpo>) </plain></SENT>
<SENT sid="4" pm="."><plain><z:mp ids='MP_0004225'>PFO</z:mp> was diagnosed [<z:mp ids='MP_0004225'>PFO</z:mp>(+)] in 57 pts (6%)-22F, 35M aged 14-77 years, mean 52.44 +/- 14.84 years </plain></SENT>
<SENT sid="5" pm="."><plain>888 pts without <z:mp ids='MP_0004225'>PFO</z:mp> [<z:mp ids='MP_0004225'>PFO</z:mp>(-)] created a control group </plain></SENT>
<SENT sid="6" pm="."><plain>Two subgroups were analyzed in the study group: xPFO(+) - 28 pts with <z:mp ids='MP_0004225'>PFO</z:mp> as the only abnormality, yPFO(+) - 29 pts with <z:mp ids='MP_0004225'>PFO</z:mp> and other heart/<z:e sem="disease" ids="C0003493" disease_type="Disease or Syndrome" abbrv="">aortic disease</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Similarly, in the control group two subgroups were analysed: xPFO(-) - pts with <z:mpath ids='MPATH_458'>normal</z:mpath> TEE and negative history of heart/<z:e sem="disease" ids="C0003493" disease_type="Disease or Syndrome" abbrv="">aortic disease</z:e> and yPFO(-) - pts without <z:mp ids='MP_0004225'>PFO</z:mp> but with other heart/<z:e sem="disease" ids="C0003493" disease_type="Disease or Syndrome" abbrv="">aortic disease</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Aneurysmal formation of interatrial septum was detected in 24 pts, and in 6 pts it coexisted with <z:mp ids='MP_0004225'>PFO</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>The intensity of shunt was significantly higher in yPFO(+) than in xPFO(+) group </plain></SENT>
<SENT sid="10" pm="."><plain>In 5 pts permanent shunt through <z:mp ids='MP_0004225'>PFO</z:mp> at the basal stage was observed (4 pts with significant regurgitation of the atrio-ventricular valves and one patient with <z:hpo ids='HP_0010446'>tricuspid stenosis</z:hpo>) </plain></SENT>
<SENT sid="11" pm="."><plain>Percentage of pts with the history of SE/<z:hpo ids='HP_0002326'>TIA</z:hpo> was significantly higher in group xPFO(+) than in xPFO(-) (p &lt; 0.01) </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: (1) <z:mp ids='MP_0004225'>PFO</z:mp> is a risk factor of SE/<z:hpo ids='HP_0002326'>TIA</z:hpo> only in group xPFO(+) </plain></SENT>
<SENT sid="13" pm="."><plain>(2) Flow through <z:mp ids='MP_0004225'>PFO</z:mp> in group xPFO(+) is generally minimal </plain></SENT>
<SENT sid="14" pm="."><plain>(3) In case of coexisting heart pathology <z:mp ids='MP_0004225'>PFO</z:mp> may provoke significant right-to-left or even left-to-right shunt </plain></SENT>
</text></document>